Chennai :

Regular clinical trials to test the toxicity of siddha drugs is essential, said Dr R S Ramasamy, director general, Central Council for Research in Siddha.

Delivering the 4th GCIM endowment oration at Sri Ramachandra University (SRU) on Saturday, he said, “Siddha medicines are being rigorously subjected to regular pharmacological studies to certify non-toxicity.” Referring to the recent uproar regarding toxicity in siddha medicines, he said constant research is being undertaken to identify toxicity in siddha medicines.

“There are fears that siddha medicine has toxicity. In order to prove them baseless and promote siddha medicine globally, we should encourage regular clinical trials,” said Dr Ramasamy.

He pointed out that 777 oil developed under siddha has been found to be effective against psoriasis and people from many parts of the country and abroad come to Chennai for treatment.

source: http://www.timesofindia.indiatimes.com / The Times of India / Home> City> Chennai / TNN / March 09th, 2014